Biovail announce plans to shed sales organization jobs

Share this article:
Canadian drugmaker Biovail announced plans to shed its US-based sales organization and related jobs in an effort to cut costs as it readies for challenges to the patent on Wellbutrin XL. The job cuts call for the elimination of 200 positions, the firm said. Biovail plans to eliminate its US specialty sales force and related support functions.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.